CAS: 461443-59-4 - 4-[4-({1-butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undec-9-yl}methyl)phenoxy]benzoic acid
Fórmula:C33H43N3O6
InChI:InChI=1S/C33H43N3O6/c1-2-3-19-36-30(38)28(29(37)24-7-5-4-6-8-24)34-32(41)33(36)17-20-35(21-18-33)22-23-9-13-26(14-10-23)42-27-15-11-25(12-16-27)31(39)40/h9-16,24,28-29,37H,2-8,17-22H2,1H3,(H,34,41)(H,39,40)/t28-,29-/m1/s1
Chave InChI:InChIKey=GWNOTCOIYUNTQP-FQLXRVMXSA-N
SMILES:O=C(O)C1=CC=C(OC2=CC=C(C=C2)CN3CCC4(C(=O)NC(C(=O)N4CCCC)C(O)C5CCCCC5)CC3)C=C1
- Sinónimos:
- 4-[4-[[(3R)-1-Butyl-3-[(R)-cyclohexylhydroxymethyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undec-9-yl]methyl]phenoxy]benzoic acid
- Ak 602
- Aplaviroc
- Apliviroc
- Benzoic acid, 4-[4-[[(3R)-1-butyl-3-[(R)-cyclohexylhydroxymethyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undec-9-yl]methyl]phenoxy]-
- Benzoic acid, 4-[4-[[1-butyl-3-[(R)-cyclohexylhydroxymethyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undec-9-yl]methyl]phenoxy]-
- Gsk 873140
- Gw 873140
- Ono 4128
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
Aplaviroc REF: 3D-BA166505CAS: 461443-59-4 | Min. 95% | A consultar | Ter 21 Jan 25 | |
Aplaviroc REF: TM-T14307CAS: 461443-59-4 | 98.78% - 99.53% | 510,00 €~4.088,00 € | Seg 10 Mar 25 |
Aplaviroc
Ref: 3D-BA166505
1mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar |
Aplaviroc
Ref: TM-T14307
1mg | 510,00 € | ||
5mg | 1.111,00 € | ||
10mg | 1.522,00 € | ||
25mg | 2.245,00 € | ||
50mg | 3.043,00 € | ||
100mg | 4.088,00 € |